Abingdon, UK, 10th January 2018. OBS Medical limited, is pleased to celebrate the announcement of Excel Medical’s successful FDA clearance for their next generation patient surveillance platform WAVE, featuring Visensia® for the advanced prediction and prevention of patient deterioration.
Read More...
Visensia Index integrated within Excel Medicals soon to be released next generation clinical decision support platform for the advanced and early detection of patient deterioration in acute care settings. Real Time Analysis & Alerting – Predictive Analytics.
Read More...
OBS Medical will once again be attending the HIMSS annual conference and exhibition to showcase Visensia – The Safety Index for the advanced and early detection of patient deterioration. Highlights include – Dr James Whitticase presentation on Connexall Booth #1903 – “Intelligent Patient Monitoring – Better Outcomes”
Read More...
OBS Medical is part of a group of UK companies representing the country’s health and life science industry in Texas. Dr James Whitticase will be promoting Visensia – The Safety Index for the advanced detection of patient deterioration.
Read More...
